biote Corp. BTMD
1.22
(0.01)
(0.81%)
as of 25 Sep
- Market cap
- $44.2M
- P/E
- 7.8×
Follow BTMD
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
3.26 | 3.02 | 2.76 | 11.81 |
P/S ratio |
0.48 | 0.42 | 0.22 | 0.29 | |
P/FCF ratio |
2.73 | 2.87 | 1.56 | 3.09 | |
P/Operating CF |
6.68 | 10.75 | 10.60 | (46.01) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.87 | 0.85 | 0.75 | 0.90 | |
EV/EBITDA |
4.68 | 4.10 | 4.21 | 8.48 | |
EV/Operating CF |
4.23 | 4.67 | 4.34 | 6.75 | |
EV/FCF |
4.92 | 5.80 | 5.36 | 9.39 | |
Quick Ratio |
0.64 | 0.69 | 0.45 | 0.63 | |
Current Ratio |
1.01 | 1.22 | 1.29 | 1.43 | |
Net Debt/EBITDA |
7.99 | 10.37 | 23.06 | (46.50) | |
Debt/Assets |
92.86% | 99.46% | 118.69% | 119.47% | |
Debt/Equity |
(1.58) | (2.12) | (2.20) | (2.09) | |
Asset Turnover |
1.84 | 1.67 | 1.77 | 1.78 | |
Operating CF/Net income |
1.72 | 3.87 | 1.71 | 0.18 | |
Capex/Depreciation |
(0.60) | (2.03) | (0.98) | (2.31) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
54.53% | 53.32% | 61.84% | 73.31% | |
Intangible Assets out of Total Assets |
0.09 | 0.09 | 0.11 | 0.09 | |
Share Based Compensation of Revenue |
5.03% | 4.74% | 3.91% | 4.45% | |
Graham Net Nets |
(1.27) | (1.27) | (2.43) | (2.16) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
30.67% | 33.08% | 36.30% | 8.47% | |
Free Cash Flow Yield |
36.61% | 34.83% | 63.92% | 32.38% | |
Revenue per Share |
1.53 | 1.48 | 1.47 | 1.55 | |
Operating CF per Share |
0.45 | 0.24 | 0.13 | (0.04) | |
Capex per Share |
(0.02) | (0.08) | (0.04) | (0.09) | |
Free Cash Flow per Share |
0.43 | 0.17 | 0.09 | (0.13) | |
Cash per Share |
0.90 | 0.77 | 0.17 | 0.39 | |
Shareholders Equity per Share |
(2.09) | (1.61) | (1.56) | (2.03) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(2.09) | (1.61) | (1.56) | (2.03) | |
Free Cash Flow |
13.38 | 5.21 | 2.73 | (3.80) | |
Working Capital |
0.82 | 9.68 | 8.13 | 12.94 | |
Capital Expenditures |
(0.69) | (2.36) | (1.17) | (2.62) | |
Net Current Asset Value |
(119.67) | (103.34) | (100.63) | (116.85) | |
EV/EBIT |
5.38 | 4.62 | 4.88 | 11.15 | |
Capex to Sales |
0.01 | 0.05 | 0.03 | 0.06 | |
Net Profit Margin |
17.07% | 4.21% | 5.07% | (14.84%) | |
Price to Operating Income |
2.99 | 2.29 | 1.43 | 3.67 | |
| Other line items | |||||
Average Receivables |
8.23 | 7.25 | 7.58 | 8.44 | |
Average Payables |
4.37 | 6.32 | 5.79 | 5.22 | |
Average Inventory |
16.32 | 16.95 | 16.67 | 15.23 | |
Average Assets |
106.29 | 114.99 | 106.21 | 103.25 | |
Average Common Equity |
(96.15) | (76.30) | (66.39) | (68.52) |
Columns are period end dates